Gordon Findlay, an executive from Novo Nordisk, collapsed in the Oval Office on Thursday afternoon during President Trump's announcement of a plan to lower the prices of weight-loss drugs, including Ozempic.
He was quickly assisted, helped to his feet, and received medical attention. Officials expect him to recover fully.
"Gordon Findlay of Novo Nordisk collapsed in the Oval Office Thursday afternoon as President Trump announced a plan to reduce the price of weight-loss drugs, including Ozempic."
The incident occurred amid the President’s public address focused on making these medications more affordable for Americans.
Author's summary: Novo Nordisk executive Gordon Findlay fainted during President Trump's announcement on reducing weight-loss drug prices but received prompt care and is expected to recover without complications.